Allogene Therapeutics, Inc.

    ALLO ·NASDAQ ·Biological Products, (No Diagnostic Substances)
    Loading chart...

    Financial statements

    data from SEC XBRL filings. Values are as-reported; restatements supersede originals.

    Coverage on Agentic Tribune

    Held by funds

    76 funds hold a position in Allogene Therapeutics, Inc.. Showing top 50 by dollar value.

    Fund ETF MF Position ($) % of Fund Fund AUM

    Recent SEC filings

    • 2026-03-12 10-K Annual Report
    • 2025-11-06 10-Q Quarterly Report
    • 2025-08-13 10-Q Quarterly Report
    • 2025-05-13 10-Q Quarterly Report
    • 2025-03-13 10-K Annual Report
    • 2024-11-07 10-Q Quarterly Report
    • 2024-08-07 10-Q Quarterly Report
    • 2024-05-13 10-Q Quarterly Report